(RTTNews) - Beckman Coulter announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The test has confirmed 98.3% positive percent agreement ...

HIGH WYCOMBE, England, Nov. 10, 2020 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries ...

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, ... Japan, and countries that accept the CE mark as the basis for their country-specific registration.

Assay has 99.9% specificity and 98.3% sensitivity at 15-30 days post-symptom onset and confirmed 95.5% positive predictive value when disease incidence is as low as 3% Beckman Coulter developed ...